kneat.com (KSI) Stock Price, News & Analysis

Company Overview

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance.

Key Stats

• Today's Range: C$5.60 to C$5.84
• 50-Day Range: C$5.18 to C$6.08
• 52-Week Range: C$4.61 to C$7.25
• Volume: 122,992 shs
• Average Volume: 100,767 shs
• Market Capitalization: C$537.81 million
• P/E Ratio: 566.00
• Dividend Yield: N/A
• Price Target: C$6.50
• Consensus Rating: Buy

kneat.com Stock Analysis - MarketRank™

kneat.com scored higher than 35% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Buy

Consensus Rating

kneat.com has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

kneat.com has a consensus price target of C$6.50, representing about 14.8% upside from its current price of C$5.66.

Amount of Analyst Coverage

kneat.com has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of kneat.com is 566.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 233.47.

Price to Earnings Ratio vs. Sector

The P/E ratio of kneat.com is 566.00, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 85.07.

Price to Earnings Growth Ratio

kneat.com has a PEG Ratio of 597.67. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

kneat.com has a P/B Ratio of 15.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KSI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

kneat.com does not currently pay a dividend.

Dividend Growth

kneat.com does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for KSI.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 1.35

News Sentiment

kneat.com has a news sentiment score of 1.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for kneat.com this week, compared to 1 article on an average week.

MarketBeat Follows

1 people have added kneat.com to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, kneat.com insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.96% of the stock of kneat.com is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 3.89% of the stock of kneat.com is held by institutions.

KSI Stock Analysis - Frequently Asked Questions

How have KSI shares performed this year?

kneat.com's stock was trading at C$5.86 on January 1st, 2025. Since then, KSI stock has decreased by 3.4% and is now trading at C$5.66.

How were kneat.com's earnings last quarter?

kneat.com, inc. (TSE:KSI) announced its earnings results on Wednesday, November, 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.06. kneat.com had a negative trailing twelve-month return on equity of 29.61% and a negative net margin of 17.59%.
Read the conference call transcript.

How do I buy shares of kneat.com?

Shares of KSI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of kneat.com own?

Based on aggregate information from My MarketBeat watchlists, some other companies that kneat.com investors own include Arista Networks (ANET), PayPal (PYPL), NVIDIA (NVDA), MercadoLibre (MELI), Enterprise Products Partners (EPD), Nextera Energy Partners (NEP) and Enbridge (ENB).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 10/16/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: TSE:KSI
• CIK: N/A
• Web: www.kneat.com
• Phone: 353 6 120 3826
• Fax: N/A
• Employees: 293
• Year Founded: N/A

Price Target and Rating

• Average Price Target for kneat.com: C$6.50
• High Price Target: C$7.00
• Low Price Target: C$6.00
• Potential Upside/Downside: +14.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): C$0.01
• Trailing P/E Ratio: 566.00
• Forward P/E Ratio: N/A
• P/E Growth: 597.67
• Net Income: -C$8.62 million
• Net Margins: -17.59%
• Pretax Margin: N/A
• Return on Equity: -29.61%
• Return on Assets: -9.84%

Debt

• Debt-to-Equity Ratio: 85.50
• Current Ratio: 1.43
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: C$56.65 million
• Price / Sales: 9.49
• Cash Flow: C$0.43 per share
• Price / Cash Flow: 13.18
• Book Value: C$0.36 per share
• Price / Book: 15.74

Miscellaneous

• Outstanding Shares: 95,019,000
• Free Float: N/A
• Market Cap: C$537.81 million
• Optionable: Not Optionable
• Beta: 1.20